Emirates Drug Establishment Approves Innovative ESR1-Targeted Breast Cancer Treatment ‘Etcamah’
Abu dhabi: The Emirates Drug Establishment (EDE) has approved AstraZeneca’s Etcamah, an oral targeted therapy for a subset of patients with advanced or metastatic breast cancer who have developed an ESR1 gene mutation detected during endocrine (hormon…